This cross-sectional study evaluated lifetime prevalence of suicide attempts in 170 HIV/AIDS patients with substance use disorders and the impact of suicide attempt history on subjective indices of quality of life and objective indices of cognitive and physical functioning. All patients met the diagnostic criteria for past-year cocaine or opioid use disorders and 27% of patients also had co-occurring alcohol use disorders. Compared to their counterparts without a history of a suicide attempt, patients with a history of a suicide attempt (n = 60, 35.3%) had significantly poorer emotional and cognitive quality of life scores (ps < .05), but not physical, social, or functional/global quality-of-life scores. Lifetime suicide attempt status was unrelated to objective indices of cognitive functioning, but there was a non-significant trend (p = .07) toward lower viral loads in those with a lifetime suicide attempt relative to those without. The findings indicate that suicide attempt histories are prevalent among HIV/AIDS patients with substance use disorders and relate to poorer perceived emotional and cognitive quality of life, but not objective functioning. HIV/AIDS patients with substance use disorders should be screened for lifetime histories of suicide attempts and offered assistance to improve perceived emotional and cognitive functioning.
Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet2008; 372: 293–299.
2.
GakharHKamaliAHolodniyM. Health-related quality of life assessment after antiretroviral therapy: a review of the literature. Drugs2013; 73: 651–672.
3.
MinersAPhillipsAKreifN. Health-related quality of life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population. Lancet HIV2014; 1: e32–e40.
4.
BlackstoneKMooreDJHeatonRK. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc2012; 18: 79–88.
5.
BucciardiniRPuglieseKWeimerL. Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients. HIV Clin Trials2014; 15: 176–183.
6.
RourkeSBHalmanMHBasselC. Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. J Clin Exp Neuropsychol1999; 21: 737–756.
7.
ThamesADBeckerBWMarcotteTD. Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance. Clin Neuropsychol2011; 25: 224–243.
8.
World Health Organization. International classification of functioning, disability, and health: ICF, Geneva: World Health Organization, 2001.
9.
HaysRDCunninghamWESherbourneCD. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med2000; 108: 714–722.
10.
BlankMBHennessyMEisenbergMM. Increasing quality of life and reducing HIV burden: the PATH+ intervention. AIDS Behav2014; 18: 716–725.
11.
JiaHUpholdCRWuS. Predictors of changes in health-related quality of life among men with HIV infection in the HAART era. AIDS Pat Care STDs2005; 19: 395–405.
12.
PsarosCO’CleirighCBullisJR. The influence of psychological variables on health-related quality of life among HIV-positive individuals with a history of intravenous drug use. J Psychoactive Drugs2013; 45: 304–312.
13.
BingEGBurnamMALongshoreD. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry2001; 58: 721–728.
14.
DeLorenze GN, Tsai A-L, Horberg MA, et al. Cost of care for HIV-infected patients with co-occurring substance use disorder or psychiatric disease: report from a large, integrated health plan. AIDS Res Treat 2014; 21: 570546.
15.
LopesMOlfsonMRabkinJ. Gender, HIV status, and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry2012; 73: 384–391.
16.
KorthuisPTZephyrinLCFleishmanJA. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Pat Care STDs2008; 22: 859–867.
17.
Ruiz PerezIRodriguez BañoJLopez RuzMA. Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors. Qual Life Res2005; 14: 1301–1310.
18.
SurahSAdamsRTownsendL. Health-related quality of life of HIV-infected intravenous drug users. Int J STD AIDS2013; 24: 867–874.
19.
SelvarajVRossMWUnnikrishnanB. Association of quality of life with major depressive disorder among people with HIV in South India. AIDS Care2013; 25: 169–172.
20.
SherbourneCDHaysRDFleishmanJA. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry2000; 157: 248–254.
21.
TostesMAChalubMBotegaNJ. The quality of life of HIV-infected women is associated with psychiatric morbidity. AIDS Care2004; 16: 177–186.
22.
DouaihyABJouRJGorskeT. Triple diagnosis: dual diagnosis and HIV disease, Part 1. AIDS Read2003; 13: 331–332, 339–341.
23.
FortinMLapointeLHudonC. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes2004; 2: 51–51.
24.
KesslerRCBerglundPBorgesG. Trends in suicide ideation, plans, gestures, and attempts in the united states, 1990--1992 to 2001--2003. JAMA2005; 293: 2487–2495.
25.
NockMKBorgesGBrometEJ. Suicide and suicidal behavior. Epidemiol Rev2008; 30: 133–154.
26.
BeautraisAJoycePMulderRUnmet need following serious suicide attempt: follow-up of 302 individuals for 30 months. In: AndrewsGHendersonS (eds). Unmet need in psychiatry: problems, resources, responses, Cambridge, UK: Cambridge University Press, 2000, pp. 245–255.
27.
FergussonDMHorwoodLJRidderEM. Suicidal behaviour in adolescence and subsequent mental health outcomes in young adulthood. Psychol Med2005; 35: 983–993.
28.
Goldman-MellorSJCaspiAHarringtonH. Suicide attempt in young people: A signal for long-term health care and social needs. JAMA Psychiatry2014; 71: 119–127.
29.
BadieeJMooreDJAtkinsonJH. Lifetime suicidal ideation and attempt is common among HIV+ individuals. J Affect Disord2012; 136: 993–999.
30.
PréauMBouhnikA-DPeretti-WatelP. ANRS-EN12-VESPA Group. Suicide attempts among people living with HIV in France. AIDS Care2008; 20: 917–924.
31.
DarkeSTorokMKayeS. Attempted suicide, self-harm, and violent victimization among regular illicit drug users. Suicide Life Threat Behav2010; 40: 587–596.
32.
Ortíz-GómezLDLópez-CanulBArankowsky-SandovalG. Factors associated with depression and suicide attempts in patients undergoing rehabilitation for substance abuse. J Affect Disord2014; 169: 10–14.
33.
RoyA. Characteristics of cocaine dependent patients who attempt suicide. Arch Suicide Res2009; 13: 46–51.
34.
PetryNMWeinstockJAlessiSM. Group-based randomized trial of contingencies for health and abstinence in HIV patients. J Consult Clin Psychol2010; 78: 89–97.
35.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV, 4th ed. Washington, DC: American Psychiatric Association, 1994.
36.
PetryNMKolodnerKBLiR. Prize-based contingency management does not increase gambling. Drug Alcohol Depend2006; 83: 269–273.
37.
PetryNMAlessiSM. Prize-based contingency management is efficacious in cocaine-abusing patients with and without recent gambling participation. J Subst Abuse Treat2010; 39: 282–288.
38.
FirstMBSpitzerRLGibbonM. Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV), Washington, DC: American Psychiatric Press, Inc, 1996.
39.
McLellanATLuborskyLCacciolaJ. New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis1985; 173: 412–423.
40.
MäkeläK. Studies of the reliability and validity of the Addiction Severity Index. Addiction2004; 99: 398–410.
41.
McLellanATCacciolaJCAltermanAI. The Addiction Severity Index at 25: origins, contributions and transitions. Am J Addict2006; 15: 113–124.
42.
CellaDFMcCainNLPetermanAH. Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res1996; 5: 450–463.
43.
PetermanAHCellaDMoF. Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res1997; 6: 572–584.
44.
SalthouseTA. What cognitive abilities are involved in trail-making performance?Intelligence2011; 39: 222–232.
45.
ArbuthnottKFrankJ. Trail Making Test, Part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol2000; 22: 518–528.
46.
ChalermchaiTValcourVSithinamsuwanP. Trail Making Test A improves performance characteristics of the International HIV-Dementia Scale to identify symptomatic HAND. J Neurovirol2013; 19: 137–143.
47.
RegerMWelshRRazaniJ. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc2002; 8: 410–424.
48.
Jovet-ToledoGGClattsMCRodriguez-DiazCE. Risk factors for suicide attempts in a clinic-based sample of people living with HIV in Puerto Rico. AIDS Care2014; 26: 1032–1035.
49.
KellyBRaphaelBJuddF. Suicidal ideation, suicide attempts, and HIV infection. Psychosomatics1998; 39: 405–415.
50.
JacksonCTCovellNHDrakeRE. Relationship between diabetes and mortality among persons with co-occurring psychotic and substance use disorders. Psychiatr Serv2007; 58: 270–272.
51.
BlackstoneKTobinAPosadaC. HIV-infected persons with bipolar disorder are less aware of memory deficits than HIV-infected persons without bipolar disorder. J Clin Exp Neuropsychol2012; 34: 773–781.
52.
CarterSLRourkeSBMurjiS. Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology2003; 17: 410–419.
53.
TombaughTN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol2004; 19: 203–214.
54.
AndradeASDeutschRACelanoS. Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons. J Acquir Immune Defic Syndr2013; 62: 282–292.
55.
BeckerBWThamesADWooE. Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav2011; 15: 1888–1894.
56.
HinkinCHCastellonSADurvasulaRS. Medication adherence among HIV+ adults. Neurology2002; 59: 1944–1950.
57.
HinkinCHHardyDJMasonKI. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS2004; 18(Suppl 1): S19–25.
58.
BradleyHHallHIWolitskiRJ. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV - United States, 2011. MMWR Morb Mortal Wkly Rep2014; 63: 1113–1117.
59.
ChhatreSMetzgerDSFrankI. Effects of behavioral stress reduction transcendental meditation intervention in persons with HIV. AIDS Care2013; 25: 1291–1297.
60.
DiamondCTaylorTHAnton-CulverH. Quality of life, characteristics and survival of patients with HIV and lymphoma. Qual Life Res2010; 19: 149–155.
61.
PersonsEKershawTSikkemaKJ. The impact of shame on health-related quality of life among HIV-positive adults with a history of childhood sexual abuse. AIDS Pat Care STDs2010; 24: 571–580.
62.
Briongos-FigueroLSBachiller-LuquePPalacios-MartinT. Depression and health related quality of life among HIV-infected people. Eur Rev Med Pharmacol Sci2011; 15: 855–862.
63.
HolmesWCBixBMeritzM. Human immunodeficiency virus (HIV) infection and quality of life: the potential impact of Axis I psychiatric disorders in a sample of 95 HIV seropositive men. Psychosom Med1997; 59: 187–192.
64.
LiuCJohnsonLMOstrowD. Predictors for lower quality of life in the HAART era among HIV-infected men. J Acquir Immune Defic Syndr2006; 42: 470–477.
